NCT00006211View on ClinicalTrials.gov

A Study of Capravirine Plus VIRACEPT Plus Two Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients Who Failed Previous Anti-HIV Treatments

PHASE2CompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

February 29, 2000

Study Completion Date

April 30, 2001

Conditions
HIV Infections
Interventions
DRUG

Capravirine

DRUG

Nelfinavir mesylate

Trial Locations (1)

92121

Lisa Bauman, San Diego

Sponsors
All Listed Sponsors
lead

Agouron Pharmaceuticals

INDUSTRY

NCT00006211 - A Study of Capravirine Plus VIRACEPT Plus Two Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients Who Failed Previous Anti-HIV Treatments | Biotech Hunter | Biotech Hunter